Clinvest Research

June is Migraine & Headache Awareness Month. 💜

At Clinvest Research, we know migraines are more than just headaches. They can disrupt work, family time, and the moments that matter most.

That's why we're proud to be part of research that advances new treatment options and brings hope to those living with migraine. Every clinical trial participant, researcher, and healthcare professional plays a role in moving care forward.

This month, we honor the strength of those affected by migraine and other debilitating headaches and reaffirm our commitment to advancing research that can improve lives today and for generations to come.

The migraine hits like clockwork.

You know the pattern. The pounding head. The sensitivity to light.

It shows up month after month, and there’s not much you can do to stop it.

A new clinical study is evaluating an investigational medication to help prevent menstrual migraines, and you may qualify to participate.

You might be eligible if you:
🙋‍♀️Are female, age 18–45
🤦‍♀️Have a history of menstrual migraine (within 2 days before to 3 days after your period starts)

Study participants may receive compensation for their time and travel.

Let’s change the future of menstrual migraines, together.

Click below to see if you qualify today!

https://clinvest.com/headache-migraine-studies/